Your browser doesn't support javascript.
loading
Positive predictive values and outcomes for uninformative cell-free DNA tests: An Italian multicentric Cytogenetic and cytogenomic Audit of diagnOstic testing (ICARO study).
Grati, Francesca Romana; Bestetti, Ilaria; De Siero, Daria; Malvestiti, Francesca; Villa, Nicoletta; Sala, Elena; Crosti, Francesca; Parisi, Valentina; Nardone, Anna Maria; Di Giacomo, Gianluca; Pettinari, Antonella; Tortora, Giada; Montaldi, Annamaria; Calò, Annapaola; Saccilotto, Donatella; Zanchetti, Sara; Celli, Paola; Guerneri, Silvana; Silipigni, Rosamaria; Cardarelli, Laura; Lippi, Elisabetta; Cavani, Simona; Malacarne, Michela; Genesio, Rita; Beltrami, Nicola; Pittalis, Maria Carla; Desiderio, Laura; Gentile, Mattia; Ficarella, Romina; Recalcati, Maria Paola; Catusi, Ilaria; Garzo, Maria; Miele, Lorena; Corti, Cecilia; Ghezzo, Sara; Bertini, Veronica; Cambi, Francesca; Valetto, Angelo; Facchinetti, Barbara; Bernardini, Laura; Capalbo, Anna; Balducci, Federica; Pelo, Elisabetta; Minuti, Barbara; Pescucci, Chiara; Giuliani, Costanza; Renieri, Alessandra; Longo, Ilaria; Tita, Rossella; Castello, Giuseppe.
Afiliación
  • Grati FR; R&D, Cytogenetics, Molecular Genetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A, Busto Arsizio, Italy.
  • Bestetti I; Laboratorio di Genetica Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • De Siero D; Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
  • Malvestiti F; R&D, Cytogenetics, Molecular Genetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A, Busto Arsizio, Italy.
  • Villa N; R&D, Cytogenetics, Molecular Genetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A, Busto Arsizio, Italy.
  • Sala E; UOS Citogenetica e Genetica Medica - ASST-Monza, Ospedale San Gerardo, Università di Milano-Bicocca, Monza, Italy.
  • Crosti F; UOS Citogenetica e Genetica Medica - ASST-Monza, Ospedale San Gerardo, Università di Milano-Bicocca, Monza, Italy.
  • Parisi V; UOS Citogenetica e Genetica Medica - ASST-Monza, Ospedale San Gerardo, Università di Milano-Bicocca, Monza, Italy.
  • Nardone AM; U.O.C. Laboratorio di Genetica Medica, Ospedale Pediatrico del Bambino Gesù, IRCCS, Roma, Italy.
  • Di Giacomo G; U.O.C. Laboratorio di Genetica Medica, Policlinico Tor Vergata, Roma, Italy.
  • Pettinari A; UOSD di Genetica Medica Ospedale, San Pietro Fatebenefratelli, Roma, Italy.
  • Tortora G; SOSD Malattie Rare e Citogenetica, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
  • Montaldi A; SOSD Malattie Rare e Citogenetica, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
  • Calò A; U.O.S. Laboratorio di Genetica, AULSS8 Berica, Vicenza, Italy.
  • Saccilotto D; U.O.S. Laboratorio di Genetica, AULSS8 Berica, Vicenza, Italy.
  • Zanchetti S; U.O.S. Laboratorio di Genetica, AULSS8 Berica, Vicenza, Italy.
  • Celli P; U.O.S. Laboratorio di Genetica, AULSS8 Berica, Vicenza, Italy.
  • Guerneri S; U.O.S. Laboratorio di Genetica, AULSS8 Berica, Vicenza, Italy.
  • Silipigni R; Laboratorio di Genetica Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Cardarelli L; Laboratorio di Genetica Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Lippi E; Laboratorio di Genetica medica, Lifebrain, Gruppo Cerba HealthCare, c/o RDI, Rete Diagnostica Italiana, Limena, Italy.
  • Cavani S; Laboratorio di Genetica medica, Lifebrain, Gruppo Cerba HealthCare, c/o RDI, Rete Diagnostica Italiana, Limena, Italy.
  • Malacarne M; U.O.C. Laboratorio di Genetica Umana, IRCCS G. Gaslini, Genova, Italy.
  • Genesio R; U.O.C. Laboratorio di Genetica Umana, IRCCS G. Gaslini, Genova, Italy.
  • Beltrami N; DAI medicina di laboratorio e trasfusionale AOU Federico II, Napoli, Italy.
  • Pittalis MC; L. C. Laboratori Campisi srl, Avola, Italy.
  • Desiderio L; IRCCS Azienda Ospedaliero Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.
  • Gentile M; IRCCS Azienda Ospedaliero Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.
  • Ficarella R; Dipartimento di Medicina della Riproduzione, UOC Genetica Medica, ASL BARI, Bari, Italy.
  • Recalcati MP; Dipartimento di Medicina della Riproduzione, UOC Genetica Medica, ASL BARI, Bari, Italy.
  • Catusi I; Laboratorio di Citogenetica e Genetica Molecolare, Istituto Auxologico Italiano, IRCCS, Milano, Italy.
  • Garzo M; Laboratorio di Citogenetica e Genetica Molecolare, Istituto Auxologico Italiano, IRCCS, Milano, Italy.
  • Miele L; Laboratorio di Citogenetica e Genetica Molecolare, Istituto Auxologico Italiano, IRCCS, Milano, Italy.
  • Corti C; Unilabs Ticino, Breganzona, Italy.
  • Ghezzo S; Unilabs Ticino, Breganzona, Italy.
  • Bertini V; Laboratorio di Citogenetica - U.O.C. Genetica Medica, Centro Servizi Pievesestina - Laboratorio Unico, AUSL ROMAGNA, Cesena, Italy.
  • Cambi F; SOD Citogenetica, Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Italy.
  • Valetto A; SOD Citogenetica, Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Italy.
  • Facchinetti B; SOD Citogenetica, Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Italy.
  • Bernardini L; UOSD SMeL 4 Citogenetica e Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Capalbo A; Medical Genetics Division, IRCCS Casa Sollievo della Sofferenza Foundation, San Giovanni Rotondo, Italy.
  • Balducci F; Medical Genetics Division, IRCCS Casa Sollievo della Sofferenza Foundation, San Giovanni Rotondo, Italy.
  • Pelo E; TECNOBIOS PRENATALE EUROGENLAB - Gruppo LIFE BRAIN Emilia-Romagna, Bologna, Italy.
  • Minuti B; SOD Diagnostica Genetica AOU, Careggi, UK.
  • Pescucci C; SOD Diagnostica Genetica AOU, Careggi, UK.
  • Giuliani C; SOD Diagnostica Genetica AOU, Careggi, UK.
  • Renieri A; SOD Diagnostica Genetica AOU, Careggi, UK.
  • Longo I; Medical Genetics, University of Siena, Siena, Italy.
  • Tita R; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Castello G; Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
Prenat Diagn ; 42(13): 1575-1586, 2022 12.
Article en En | MEDLINE | ID: mdl-36403097
OBJECTIVES: To establish the positive predictive values (PPV) of cfDNA testing based on data from a nationwide survey of independent clinical cytogenetics laboratories. METHODS: Prenatal diagnostic test results obtained by Italian laboratories between 2013 and March 2020 were compiled for women with positive non-invasive prenatal tests (NIPT), without an NIPT result, and cases where there was sex discordancy between the NIPT and ultrasound. PPV and other summary data were reviewed. RESULTS: Diagnostic test results were collected for 1327 women with a positive NIPT. The highest PPVs were for Trisomy (T) 21 (624/671, 93%) and XYY (26/27, 96.3%), while rare autosomal trisomies (9/47, 19.1%) and recurrent microdeletions (8/55, 14.5%) had the lowest PPVs. PPVs for T21, T18, and T13 were significantly higher when diagnostic confirmation was carried out on chorionic villi (97.5%) compared to amniotic fluid (89.5%) (p < 0.001). In 19/139 (13.9%), of no result cases, a cytogenetic abnormality was detected. Follow-up genetic testing provided explanations for 3/6 cases with a fetal sex discordancy between NIPT and ultrasound. CONCLUSIONS: NIPT PPVs differ across the conditions screened and the tissues studied in diagnostic testing. This variability, issues associated with fetal sex discordancy, and no results, illustrate the importance of pre- and post-test counselling.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácidos Nucleicos Libres de Células Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Prenat Diagn Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácidos Nucleicos Libres de Células Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Prenat Diagn Año: 2022 Tipo del documento: Article País de afiliación: Italia
...